PCM
ARCT icon

Portolan Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Portolan Capital Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-129,144
Closed -$3M – 135
2024
Q3 		$3M Sell
129,144
-355,763
-73% -$7.61M 0.22% 110
2024
Q2 		$11.8M Buy
484,907
+240,248
+98% +$7.29M 0.97% 38
2024
Q1 		$8.26M Buy
244,659
+98,805
+68% +$3.5M 0.63% 59
2023
Q4 		$4.6M Sell
145,854
-130,651
-47% -$3.11M 0.4% 81
2023
Q3 		$7.06M Buy
+276,505
New +$8.52M 0.66% 48

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return